dividends
NASDAQ · BTX
BlackRock Technology and Private Equity Term Trust
Healthcare · Biotechnology
$8.46
Down-$0.21 (-2.42%)
Updated Sep 16, 2026, 6:21 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 790.71M
- P/E ratio
- 40.96
- Dividend yield
- 11.08%
- 52-week range
- $6.13 – $9.44
- Volume
- 705K
- Avg. volume
- 929.73K
Price performance
BTX price history
1M range · 20 trading sessions · Daily adjusted prices
BTX closed at $8.46 after 20 trading sessions, down 5.79% for the selected period.
- Last close
- $8.46
- Period change
- -5.79%
- Period low
- $8.46
- Period high
- $9.06
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $8.60 | $8.771 | $8.46 | $8.46 | 705K |
| Sep 14, 2026 | $8.70 | $8.71 | $8.59 | $8.67 | 340.24K |
| Sep 11, 2026 | $9.01 | $9.01 | $8.825 | $8.87 | 301.44K |
| Sep 10, 2026 | $8.82 | $8.90 | $8.80 | $8.81 | 346.33K |
| Sep 9, 2026 | $9.01 | $9.13 | $8.96 | $8.96 | 356.94K |
| Sep 8, 2026 | $9.00 | $9.06 | $8.94 | $9.01 | 299.09K |
| Sep 4, 2026 | $8.87 | $8.95 | $8.83 | $8.94 | 282.34K |
| Sep 3, 2026 | $8.83 | $8.90 | $8.78 | $8.82 | 465.1K |
| Sep 2, 2026 | $8.90 | $8.9924 | $8.81 | $8.81 | 467.99K |
| Sep 1, 2026 | $8.89 | $8.935 | $8.79 | $8.91 | 543.57K |
| Aug 31, 2026 | $8.98 | $9.06 | $8.91 | $8.94 | 386.33K |
| Aug 28, 2026 | $9.09 | $9.1198 | $8.88 | $8.96 | 461.03K |
| Aug 27, 2026 | $9.07 | $9.11 | $9.02 | $9.06 | 344.91K |
| Aug 26, 2026 | $8.86 | $8.96 | $8.86 | $8.93 | 275.72K |
| Aug 25, 2026 | $8.83 | $8.90 | $8.82 | $8.86 | 400.19K |
| Aug 24, 2026 | $8.95 | $8.991 | $8.78 | $8.80 | 450.63K |
| Aug 21, 2026 | $9.03 | $9.3725 | $8.915 | $9.01 | 306.81K |
| Aug 20, 2026 | $8.81 | $8.99 | $8.81 | $8.99 | 415.78K |
| Aug 19, 2026 | $9.09 | $9.09 | $8.81 | $8.88 | 511.72K |
| Aug 18, 2026 | $9.10 | $9.15 | $8.91 | $8.98 | 461.27K |
Latest BTX news
The latest Smart Investors Daily articles mentioning BTX.
Stock researchCompany · Overview
BTX research
Overview
Company profile and research snapshot.
Company profile
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 12, 2022 | Maxim Group | Hold | — |
| Dec 29, 2021 | Cantor Fitzgerald | Overweight | — |
| Oct 6, 2021 | Maxim Group | Buy | — |
| Mar 18, 2019 | Raymond James | Outperform | — |
| Feb 21, 2019 | H.C. Wainwright | Buy | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.